Inotek raises $28 million

Inotek Pharmaceuticals Corp. (Lexington, Mass.) raised $21 million in a series B round and $7 million in a venture debt financing. All existing investors participated in the venture round, including Devon Park Bioventures; Rho Ventures; Care Capital; Medimmune Ventures; and Pitango. Horizon Technology Finance led the debt financing. ...